MAGIC GA Meeting 2026 San Sebastián
MAGIC Horizon Project Holds Its 4th General Assembly in San Sebastián The MAGIC Horizon consortium successfully convened for its 4th General Assembly on 1–2 June 2026 in San...
MAGIC Consortium welcomes new partners to strengthen technology development and exploitation activities
iMM has joined the MAGIC Project to advance biomedical research by enhancing muscle-on-chip technologies and the development of new disease models.
Rare Disease Day with the MAGIC team
Rare Disease Day is observed every year on 28 February. It was established and coordinated by EURORDIS in partnership with over 70 national alliance patient organisations to...
MAGIC Experts Share Knowledge Through Interactive Workshops
As part of our annual General Assembly meeting in Lisbon (27–30 October 2025), MAGIC hosted a series of workshops designed to share expertise with the wider research community....
MAGIC GA Meeting 2025 Lisbon
MAGIC partners gather in Lisbon for annual General Assembly The MAGIC consortium held its annual General Assembly from 28–30 October in Lisbon, hosted by our partners at the...
Meet CRICK in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Mariam Zouhair, Postdoctoral Project Research Scientist at the Francis Crick Institute.
Meet NUIM in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Prof. Karen English, Immunologist at Maynooth University.
Meet DINAMIQS in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Eduard Ayuso, Chief Technology Officer at Siegfried DINAMIQS.
Meet UPEC in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Frédéric Relaix, a Professor at Université Paris-Est Créteil Val de Marne (UPEC).
Meet Cure CMD in the MAGIC Project Consortium
We ask MAGIC partners why they are joining this project. This time, we are speaking with Gustavo Dziewczapolski, Scientific Director at Cure CMD.